ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Ambar Protein Industries approved unaudited standalone results for the quarter and half year ended 30 September 2026. The auditors issued a limited review report.
Ambar Protein will hold a board meeting on November 5, 2026 to consider quarterly results. Trading window closes for insiders until 48 hours after results.
Ambar Protein Industries Ltd has filed its quarterly Shareholding Pattern for the quarter ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
Ambar Protein Industries Limited conducted its 33rd Annual General Meeting on September 30, 2026. Shareholders considered nine resolutions including financial statement adoption and director re-appointments.
Ambar Protein Industries Ltd has announced the closure of its share transfer books from September 24, 2026, to September 30, 2026, for its Annual General Meeting.
Ambar Protein Industries Ltd submitted its Annual Report for FY 2025-26, including the notice for the 33rd Annual General Meeting.
Ambar Protein Industries Ltd reported revenue from operations of ₹113.4 Cr (-3.3% YoY) and net profit of ₹3.8 Cr (+442.9% YoY) for Q1 FY27.
Ambar Protein Industries scheduled a board meeting for August 14, 2026, to discuss unaudited financial results and other operational matters.
Ambar Protein Industries clarified no undisclosed price-sensitive info exists. Share price movement is attributed to market conditions beyond company control.
Promoter Pradeep K. Khetani bought 13,200 shares (0.23%) of Ambar Protein Industries in an open‑market transaction on 23 June 2026. His holding rose to 12.66%.
Promoter Pradeep Kumar Chunilal Khetani acquired 22,378 shares (0.39%) via open market on June 9, 2026. His stake rose to 12.35%, signaling continued promoter confidence.
Ambar Protein Industries Ltd reported revenue from operations of ₹146.8 Cr (+14.9% YoY) and net profit of ₹2.5 Cr (+0.0% YoY) for Q4 FY26.
Ambar Protein Industries approved audited FY26 financial results, reporting annual revenue of ₹500.66 Crore. The Board also re-appointed Rajendra Natverlal Shah & Co. as internal auditors.
Ambar Protein Industries filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor confirmed the company maintained proper governance standards with no observed non-compliances.
Ambar Protein Industries scheduled a board meeting for May 30, 2026. Directors will approve audited annual results and evaluate related party transactions with Ankur Oil Industries.
Ambar Protein Industries Ltd confirmed it does not fall under the 'Large Corporate' category for the financial year ended March 31, 2026. Consequently, the company reported nil incremental borrowing and no mandatory debt security issuance requirements under SEBI's large corporate framework for the 2025-26 period.
Ambar Protein Industries Ltd submitted an initial disclosure confirming it does not fall under the 'Large Corporate' category as of March 31, 2026. The company reported outstanding borrowings of ₹12.22 Crore, which is below the regulatory threshold specified in the SEBI Circular regarding fund raising by debt securities.